|
|
|
|
|
|
Monday, 07/16/07 - Stat
Capture Bar:
DOW:
13,951
+44
|
Nasdaq:
2,697
-10
|
S&P
500: 1,550
-3 |
|
PRO/CON |
STOCK |
CLOSING
PRICE
THAT
DAY |
OPENING
PRICE
NEXT
DAY |
JIM
CRAMER'S COMMENTS |
|
|
 |
LIFC |
31.51 |
31.52 |
LifeCell
LIFC - You know, I've liked
LIFC. I've had them on. It's
a terrific company. I like LIFC.
I like Allergan (AGN)
and, even though people are cutting
numbers for Medicis (MRX),
I'm not going to run away from MRX now.
I think Jonas Shaknai can deliver.
I think you've got a good one in LIFC.
Understand, that dermatology market
right now... out of favor, but every
time we run away from a group that's out
of favor, we forget things like DJO
Orthopedics (DJO),
which we recommended here
in November, and we got a quick
14%... So I like your LIFC. |
|
 |
AGN |
58.30 |
58.50 |
Allergan
See LIFC comments above for:
AGN |
|
 |
MRX |
30.99 |
31.05 |
Medicis
See LIFC comments above for:
MRX |
|
 |
SNCR |
33.97 |
34.52 |
Synchronoss Technology
SNCR - You know, if this
company hadn't come public last year
with Goldman Sachs, you would think it
would be LBO'd... (leverage buy out)...
This is just the kind of consistent
service business I like. I know
SNCR, because they are the guy who
synchronizes the bills for my favorite,
which is Level 3 (LVLT).
They have a lot - a lot - of telco
companies in their stable. I think
SNCR is a really good company. I
think Goldman gave it away, it was
brought (to IPO) so low last year. |
|
 |
TGT |
69.20 |
69.15 |
Target Corp.
TGT - All right, let's
understand each other. Bill
Ackman, from Pershing Capital... he
bought a very big stake... he's got
9%+... I think that there's not much you
can really do with TGT, other than wreck
it, because it's one of my favorite
places to shop, and it has done really
well... Anyway, I would ring the
register for TGT... Sell, sell, sell!
And I would buy - yes! - Walmart
(WMT),
where the turn is at hand and, if Lee
Scott leaves... plus 5... |
|
 |
WMT |
48.94 |
48.76 |
Walmart
See TGT comments above for:
WMT
Price target if CEO Lee Scott leaves:
$53.94 |
|
 |
RYAAY |
39.02 |
38.96 |
Ryanair Holdings
RYAAY - Nope. Nope.
I agree with you. I think that
oil's going to $80 a barrel. I've
been recommending the GOL Airlines
(GOL),
which is the Brazilian airline... I've
got to tell you something... I
think this group is just really bad.
Sell, sell, sell!... |
|
 |
TWX |
20.93 |
20.97 |
Time Warner
TWX - My friend, Rich
Greenfield... I read his research this
morning. I totally agree.
They're going to break the company up,
because it's too difficult to
understand... I told my friend, Regis
Philbin, recently to please not give up
on TWX... I'm reiterating that
right here... and may I just say for the
record that Regis is my idol, when it
comes to entertainment. I mean, if
I can have that kind of longevity,
there's going to be a lot of bull... |
|
|
|
|
|
|
|
|
PRO/CON |
STOCK |
CLOSING
PRICE
THAT
DAY |
OPENING
PRICE
NEXT
DAY |
JIM
CRAMER'S COMMENTS |
|
|
 |
TLAB |
11.89 |
11.88 |
Tellabs
TLAB - You know what? I
think the estimates are so low, that the
comparisons are so easy. (buzzer
sounds)... I have to explain this,
because I'm not a big fan of TLAB...
Here's the deal with TLAB... Someone has
to acquire them, and the business is
just keeping up that it could happen.
I am going to violate my rules... and I
am going to say (bull)... own TLAB... I
hope that I don't have to pay for that
one. |
|
 |
DNA |
75.19 |
74.90 |
Genentech
DNA - I am worried. The
Evastin sales apparently are being cut
in half. People are realizing that
they don't have to do the big dosing.
The quarter was great. A lot of my
friends like it, but I have to tell you,
I am reiterating that, if you want
regular bio, you go with Celgene
(CELG),
which looks like Gilead (GILD)
a year ago; and, if you want a little
speculative, you go with Nastech
(NSTK)...
I am saying ix-nay on your DNA,
unfortunately... Sell, sell, sell!...
and saying yes to CELG. |
|
 |
CELG |
58.32 |
58.54 |
Celgene
See DNA comments above for:
CELG
|
|
 |
NSTK |
11.89 |
11.90 |
Nastech
See DNA comments above for:
NSTK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[
end of lightning round ] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[
end of lightning round ] |
|
|
>> Go to next segment (Closing
Segment Comments...)
Back to top
|
|
|
|
|
Jim
Cramer's Mad Money recap summary from the CNBC TV show. |
|
|
|
|
|
|
| |
KEY TO SYMBOLS: |
 |
|
|
 |
|
|
|
|
|
|
|
Definition: 'Pull the
trigger' is Jim's phrase for making
the decision at that point to 'buy'...
Definition: 'backing it up'
or 'doing a 'mon-back' is Jim's
phrase for the metaphor of backing up a
truck to load up on a stock by buying
it. 'Mon-back is short for the
imaginary worker saying, 'Come on
back...' as the truck is backing up to
receive its load... Notice that we use
the little truck icon to indicate where
Jim has mentioned this.
|
|
We need your help!
If you find our service valuable, your
donation in any amount, large or small is
MUCH appreciated!
(click below to donate) |
We thank you for your
support & generosity!
Enjoy our site!
|
|
|
|
| |
= Special Mention/Conversation |
| |
= Lightning Round Mention
= Sudden Death lightning round stock
picks - at end of show
= Recommended 'Mon-back...
= Jim was stumped and he will come back to
it...
'MON-BACK - This is Jim Cramer's term
to indicate that he would back up a
figurative truck, saying "Come on back" or do
a 'mon-back' and load up on the stock being
mentioned.
* Indicated this stock owned by Cramer's Charitable
Trust on this day.
 |
|
|
|
|
|
|
|
|
© 2007
MadMoneyRecap.com ● This site is not affiliated with Mr.
James Cramer, and is not associated with any television
networks or broadcasts. Please note that all
thumbs up or thumbs down indicators are not always
clearly indicated on the show and are interpreted by us
as accurately as possible. Please rely on watching
the show yourself, and reading the text of the comments
to draw your own conclusions. Also, data presented
on this site should not be used to make investment
decisions and accuracy, although attempted, cannot be
guaranteed. |
|
|
|
|
|